Abstract Sixteen Japanese nonsyndromic autosomal dominant sensorineural hearing loss (ADSNHL) families were investigated clinically as well as genetically. Most families showed postlingual hearing loss. Although the severity of their hearing loss varied, most patients showed mildmoderate sensorineural hearing loss of a progressive nature. Mutation analysis was performed for the MYO7A, KCNQ4, and GJB3 genes, which are known to be responsible for autosomal dominant sensorineural hearing loss. The present study reports that a mutation in KCNQ4, a member of a large family of potassium channel genes, was responsible for ADSNHL in one Japanese family.
Introduction
Recent molecular genetic studies have revealed the genes responsible for hereditary hearing impairment, and it has become possible to diagnose various types of hearing loss from the molecular genetic viewpoint. This is noteworthy because of the possible molecular diagnostic applications for individual affected patients.
For example, several reports have demonstrated that GJB2 accounts for the majority of autosomal recessive sensorineural hearing loss (ARSNHL) in several regions, including European countries (Denoyelle et al. 1997) , the United States (Kelley et al. 1998) , Japan (Abe et al. 2000) , and Korea (Park et al. 2000) . This gene is currently considered to be the first gene to screen for ARSNHL.
In contrast, for autosomal dominant sensorineural hearing loss (ADSNHL; which accounts for 30% of nonsyndromic hereditary hearing loss), the clinical and genetic features of nonsyndromic ADSNHL are not yet fully understood. This is because, although 36 loci (DFNA1-36) and 11 genes for ADSNHL have already been reported, most were identified in only a single or a few families. It is therefore clinically important to know which genes are major causes of Japanese ADSNHL.
Currently, two loci, DFNA11 (Tamagawa et al. 1996 ) and DFNA16 (Fukushima et al. 1999) , have been reported for Japanese ADSNHL. Furthermore, an in-frame 9-bp deletion of exon 22 of MYO7A, which is responsible for Usher type 1b (USH1B) (Wiel et al. 1995) and DFNB2 (Liu et al. 1997a; Wiel et al. 1997) , was demonstrated in a DFNA11 family (Liu et al. 1997b ). This suggests that MYO7A is, possibly, a major cause of Japanese ADSNHL.
Although the number of individuals in each of the 16 families in the present study is too small to draw conclusions about DFNA loci, our preliminary linkage analysis (not shown) suggested that at least 1 family was compatible with linkage to the DFNA2 locus. Because this locus was recently reported to contain two genes responsible for hearing loss, KCNQ4 and GJB3, mutation screenings for these two genes were performed to determine whether they are common genes responsible for Japanese ADSNHL.
Another aim of this study was to summarize the clinical data of ADSNHL to determine whether there is a general characteristic feature.
Subjects and methods

Subjects
Forty-four subjects from 16 independent ADSNHL families (with two or more generations affected) were analyzed both genetically and clinically.
Clinical evaluation
Pure-tone audiometry was performed in all 44 subjects. The criterion used to consider an individual affected was bilateral sensorineural hearing loss of more than 30 dB in at least one frequency with pure-tone audiometry. Severity of hearing loss was evaluated by a three-frequency average of 500, 1000, and 2000 Hz. The age at onset, degree of hearing loss, and presence of progression, tinnitus, and vertigo were evaluated in all affected individuals. Some patients underwent computerized tomography (CT) scan examination for inner ear malformations. For a selected family, we performed detailed auditory and vestibular testing, including Békésy audiometry, short increment sensitivity index (SISI) test, distortion product otoacoustic emission (DPOAE) test, and caloric test.
Genetic analysis
Blood samples from the 16 Japanese ADSNHL families, obtained with informed consent, were used in this study. Control samples were obtained from 96 Japanese subjects with normal hearing.
MYO7A
MYO7A consists of 49 exons. Polymerase chain reaction (PCR) amplification primers flanking each exon (Weston et al. 1996; Lévy et al. 1997) were used. Heteroduplex analysis was performed as previously described (Weston et al. 1996) . Samples showing abnormal bands on heteroduplex analysis were further analyzed by direct sequencing with an ABI 377 sequencer (Perkin Elmer, CA, USA).
KCNQ4
KCNQ4 consists of 14 exons. Each exon was amplified using intronic primers as described previously (Kubisch et al. 1999; Van Hauwe et al. 2000) . Direct sequencing was carried out to detect the mutations.
GJB3
GJB3 consists of 1 exon. The details of the PCR amplification were as described previously (Xia et al. 1998 ). All samples were analyzed by direct sequencing.
Results
Clinical features of ADSNHL
All patients had hearing loss. Severity of hearing loss (three-frequency average of 500, 1000, and 2000 Hz) varied from mild to profound; 31.8% of the patients showed mild hearing loss (30-49dB), 29.5% had moderate hearing loss (50-69 dB), 13.6% had severe hearing loss (70-89 dB), and 15.9% had profound hearing loss (Ͼ90 dB). The age at onset also varied, from congenital to the fifties. Twenty-four persons (55%) had progressive loss, 15 persons (34%) had tinnitus, and 10 persons (23%) complained of vertigo. CT examination was performed for 31 patients, but no malformations of the inner ear were identified. Table 1 summarizes the clinical features of the present ADSNHL families.
Genetic analysis
MYO7A
Two polymorphic sites were identified: a T AE A substitution at nucleotide position 4996 in exon 36, which converts cysteine residue at codon 1666 to serine, and a A AE C substitution at nucleotide position 5860 in exon 43, which alters isoleucine at codon 1954 to leucine. But these two base changes were also detected in the 96 normal controls at a high frequency (C1666S, 41% of alleles; I1954L, 66% of alleles).
KCNQ4
In exon 5 of the KCNQ4 gene, a mutation of G AE C was identified at nucleotide position 827 in the DFNA2-compatible family, and this missense mutation leads to the replacement of tryptophan by serine (Fig. 1 ). This W276S mutation, which was not found in the 96 normal controls, CP, canal paresis; DP, directional preponderance; CT, computerized tomography; hetero, heterozygous; homo, homozygous was highly segregated in the family, and all affected members had this mutation. The pedigree of the family with the KCNQ4 mutation is shown in Fig. 2 . This family was affected in four generations. Genetic as well as clinical evaluation was performed in seven members (five affected, two unaffected). The detailed audiometric data of the five affected members are summarized in Table 2 . All the affected subjects presented a postlingual high frequencies-predominant hearing impairment that was not associated with tinnitus. They had noticed their hearing impairment at the age of 7-12 years, and had gradual progression. Audiograms of subjects IV-1 and IV-2 showed the progression of hearing loss over the testing period (Fig. 3) . In all patients, Békésy audiograms showed a type II pattern, and a high SISI score was noted. The DPOAE response was not obtained in any affected patients. Two subjects reported vertigo. Caloric testing showed unilateral poor response in one subject (II-2) and one patient (IV-2) had an episode of epilepsy.
GJB3
No mutations were identified in the GJB3 gene.
Discussion
As show in Table 1 , the present study revealed common as well as variable clinical features of ADSNHL. First, with regard to the onset of hearing loss, the majority (14 of the 16 families) showed postlingual rather than congenital loss. Secondly, individual hearing levels varied, but most (61.4%) showed mild-moderate hearing loss. Patients with severe-profound hearing loss (over 70 dB) were usually older. Thirdly, most patients recognized progression of hearing loss. Patients who did not feel progression were young. No malformations of the inner ear were identified by CT examination, suggesting that the hearing loss was not caused by deformities of the inner ear. From the observation of these clinical features, ADSNHL has more or less common features, although there is still interindividual variation.
In the genetic analysis of the MYO7A gene, two base changes in exons 36 (C1666S) and 43 (I1954L) were identified. These mutations, however, were also detected in normal controls at a high frequency (41% of alleles for C1666S and 66% of alleles for I1954L). There was no significant shown. Subject numbers are those shown in the pedigree in Fig. 2. y. o., Years old difference in allele frequencies between the patient group and the controls. Therefore, in spite of the amino acid conversion, these mutations of the MYO7A gene are certainly polymorphisms, and not disease-causing mutations. Many polymorphic sites have been reported in the MYO7A gene (Weston et al. 1996; Janecke et al. 1999 ). The present results add two common polymorphic sites in MYO7A, and suggest that the MYO7A gene is unlikely to be the major gene responsible for Japanese ADSNHL.
The present study is the first to describe a mutation in the KCNQ4 gene in Japanese with ADSNHL, the second gene after MYO7A reported to be responsible for ADSNHL in that population. KCNQ4, a member of a large K ϩ channel family, has been thought to play an important role in K ϩ recycling. An in-situ hybridization study has indicated that KCNQ4 mRNA is expressed in the inner ear hair cells (both cochlear and vestibular) (Kharkovets et al. 2000) . At present, seven mutations of the KCNQ4 gene have been identified Kubisch et al. 1999; Talebizadeh et al. 1999; Van Hauwe et al. 2000) . Five mutations have been found in exons coding for the KCNQ4 P-loop domain (Talebizadeh et al. 1999; Van Hauwe et al. 2000) . Interestingly, W276S, seen in our Japanese family, was also found in a Dutch family . The fact that this mutation was found across racial differences suggests that this is, possibly, a mutational hotspot in the KCNQ4 gene. On the other hand, there is a very slight possibility that the mutations may be related through a common ancestor. We have confirmed, by means of haplotype analysis, that the hotspot explanation is most likely (van Camp, manuscript in preparation). The W276S mutation, located in a critical domain of the protein, replaces tryptophan (W) by serine (S). Because it is necessary to aggregate four KCNQ4 subunits to form a functional channel, this mutation may exert a dominant negative effect.
A W276S missense mutation in exon 5 of the KCNQ4 gene was found in all affected family members. As shown in Table 2 , all family members had postlingual onset (at the age of 7-12 years) and moderate-severe, progressive, highfrequency-involved sensorineural hearing loss. These audiological features of the patients with KCNQ4 mutations are mostly in line with the previous reports on a Dutch family, and there were no significant differences between our findings and these in the Dutch family (see Van Hauwe, 1999 for review). As for the detailed audiometric evaluation, all family members showed Jerger type II Békésy audiometry findings, positive SISI test, and poor response to the DPOAE test, suggesting that the origin of their hearing loss was, most likely, the inner ear. Two of the affected family members had had episodes of vertigo. As KCNQ4 is also expressed in vestibular hair cells (Kharkovets et al. 2000) , it is conceivable that such vertigous symptoms are caused by vestibular dysfunction. One patient had had an episode of epilepsy. Epilepsy has been reported in patients carrying mutations of the KCNQ2 or KCNQ3 genes (Biervert et al. 1998; Charlier et al. 1998; Singh et al. 1998) , which are members of the same K ϩ channel family. Further discussion will be needed to reach a conclusion as to whether epilepsy is one component of KCNQ4 mutation.
However, symptoms such as vertigo and epilepsy should be carefully taken into consideration when patients with ADSNHL are observed.
There were no mutations in GJB3 (connexin 31) in the families studied, suggesting that this gene may not be a major cause of Japanese ADSNHL.
To summarize, the present study revealed the first Japanese ADSNHL family associated with KCNQ4. However, the gene responsible for ADSNHL in the majority of families remains unclear, and no common genes causing ADSNHL have been reported. Efforts should be continued to find such a common gene. It is also possible that there is no such single common gene, but that many genes contribute to ADSNHL; in other words, ADSNHL may exhibit genetic heterogeneity. The variable clinical features of the condition may support this idea.
